In studies on the mechanism of leukocyte chemotaxis, Ward and Becker have observed that preincubation of rabbit peritoneal neutrophils with chemotactic products of complement activation induces an irreversible loss of their response to a subsequent chemotactic stimulus (32) . They termed this phenomenon "deactivation." More recently, chemotactic deactivation of human eosinophils (34) and polymorphonuclear neutrophils (PMN) (8, 18, 21) has also been reported.
Although the mechanism of deactivation remains unresolved, Ward and Becker have offered several explanations to account for this phenomenon (31) . Among these, the mechanism most frequently cited involves an esterase enzyme which is activated from its proenzyme form on interaction of the neutrophil with activated complement; activation of available proesterase followed by rapid decay of labile "activatable" esterase activity during the preincubation period is thought to be the biochemical basis of deactivation (3, 31, 32) . Another mechanism which may also contribute to the deactivation phenomenon may involve the cytotaxin-induced production of highly reactive species of oxygen (13, 15, 16) . Autoxidative reactions attributable to excessive production of such agents have been found to alter a number of functions of PMN stimulated by other means (6, 7, 20, 26) . To assess the possible relationship of deactivation to cytotaxin-mediated stimulation of oxidative metabolism, we have studied the effect of the deactivation protocol on spontaneous and chemotactic migratory functions of PMN from patients with chronic granulomatous disease. Leukocytes from such patients provide a unique opportunity to separate the effects of chemotaxis-related events from those associated with stimulation of oxidative metabolism, since PMN from such patients are deficient in their ability to produce superoxide and, therefore, other reactive forms of oxygen (5).
MATERIALS AND METHODS
Preparation of PMN. Blood was drawn from healthy donors and patients with the clinical diagnosis of chronic granulomatous disease in heparinized syringes, and PMN were isolated as previously described (23) .
Measurement of PMN chemotaxis and spontaneous migration. The chemotactic and spontaneous migratory functions of purified populations of PMN were assessed by the chemotaxis-under-agarose method as previously described (23) We next studied the effect of preexposure of PMN from two patients with chronic granulomatous disease (CGD) to these cytotaxins. Neutrophilic granulocytes from both of these a Migratory responses tested include chemotaxis toward ZAS (CT,ZAS), chemotaxis toward N-formyl methionylphenylalanine (CT,FMP), and spontaneous migration (SM). Data denote mean percent depression of migratory response tested ± standard deviation.
b ZAS and F-Met-Phe were at 50% and 1.5 x 1O-4 M, respectively.
-, Not tested.
patients have been previously studied in our laboratories and found to be normally responsive chemotactically to ZAS but abnormally responsive to manipulations which are known to stimulate oxidative metabolism (data not shown). It has been our experience with three CGD patients, using the chemotaxis-under-agarose assay (unpublished data), and the experience of Cates and Quie with eight CGD patients, using the membrane filter method (L. Cates and P. G. Quie, personal communication), that in the absence of infectious complications the spontaneous and chemotactic migratory responses of PMN from CGD patients are within normal limits.
In two experiments, PMN isolated from a CGD patient and from a control subject were preincubated in MEM, 50% ZAS, or 1.5 x 1O-4 M F-Met-Phe and washed, and their subsequent migratory functions were tested. The results of these experiments are summarized by data presented in Table 2 . The untreated PMN from both CGD patients were observed to have normal spontaneous and chemotactic migratory function. Preexposure of the PMN from the healthy donors to either ZAS or F-Met-Phe significantly reduced spontaneous migratory activity and chemotactic responses to both cytotaxins. In contrast, these migratory functions of the treated PMN from the two CGD patients were either unaffected or only minimally reduced as a consequence of preexposure to these cytotaxins. DISCUSSION For the studies described which have dealt with activated complement-mediated chemotaxis and deactivation of neutrophils, we have used activated complement in the form of zymosan-activated serum. Although it is not possible to argue with absolute certainty that these influences of ZAS can be attributed to products VOL. 23, 1979 on August 27, 2017 by guest http://iai.asm.org/ of activated complement, the complement dependency ofsuch effects of activated serum demonstrated in other reports (18, 20, 28) leads us to believe that ZAS is an acceptable substitute for the more purified complement fractions in the experiments described. Our experience that the chemotactic and deactivating functions of the serum used are not expressed if the serum is heated to 500C for 30 min before incubation with zymosan is further evidence that the effects of ZAS described in this report are complement dependent.
Another question which arises with respect to our protocol is the reality of the deactivation phenomenon we have reported. One could argue that excessive carryover of cytotaxin in the final cell suspension medium could reduce neutrophil chemotaxis and spontaneous migration to mimic the deactivation phenomenon. However, we believe that the cytotaxin-mediated reduction of these migratory functions we report is attributable instead to deactivation as described originally by Ward and Becker (31) due to the following observation. When a portion of the final wash fluid is used as an attractant or as the cellsuspending medium, we find that this fluid is neither chemotactic nor inhibitory for spontaneous migration or chemotaxis of untreated cells toward optimal concentrations of multiple cytotaxins.
The results we have presented (Table 1) (18) and demonstrate that complement-mediated chemotactic deactivation is not a phenomenon unique to rabbit peritoneal neutrophils. We have demonstrated, furthermore, that synthetic cytotaxin FMet-Phe, like activated complement, possesses deactivating activity (Table 1) . These results corroborate those reported by Goetzel for the effect of the tetrapeptide Val-Gly-Ser-Glu on eosinophil migratory responses (12) and those by Showell et al. for the effects of N-formyl methionyl oligopeptides on lysosomal enzyme released from human neutrophils (H. J. Showell, P. H. Naccache, G. Vitkauskas, D. Williams, R. Sha'afi, and E. L. Becker, Fed. Proc. 37:1565 , 1978 .
A relationship of deactivation to the cytotaxin-induced respiratory burst of normal human PMN is suggested by our observation that migratory functions of CGD PMN were either not altered or only minimally reduced by preexposure to ZAS or to F-Met-Phe (Table 2) . Since all migratory responses of the untreated patient PMN were normal, it seems much less probable that their failure to deactivate could be due instead totally to mechanisms, such as activation and loss of an esterase enzyme activity, needed for normal migratory functions (31) . Although an activatable esterase enzyme analogous to that identified in rabbit neutrophils has not been demonstrated in human PMN, it seems beyond doubt that such an enzyme must exist, and reasonably certain that the levels of its proesterase and activated forms are within normal limits in CGD PMN. Therefore, to apply the latter mech-284 NELSON ET AL.
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Alternatively, it is possible that activation of this esterase enzyme activity may be related to stimulation of multiple neutrophil functions, including oxidative metabolism, rather than exclusively to cell migratory responses. In support of this possibility are the reported observations that other nonmigratory responses of leukocytes are associated with activatable esterase activity (10, 17, 25) . Thus, in protecting rabbit neutrophils from complement-mediated deactivation by addition of aromatic amino acid derivatives, which may bind with the activatable esterase (31), Ward and Becker may have effectively blocked complement-induced stimulation of oxidative metabolism of the treated cells. In further support of our proposal, we have observed that crude E. coli-derived chemotactic factor, which neither deactivates (30) nor induces activation of significant rabbit neutrophil esterase activity (3), also fails to stimulate human neutrophil oxidative metabolism as measured by the chemiluminescence phenomenon.
We have recently reported that the deactivation phenomenon may have two components (22) . Preexposure of neutrophils to greater concentrations of cytotaxin results in inhibition of a subsequent spontaneous migratory response and chemotactic responses to both the deactivating and other cytotaxins: the nonspecific component. Preincubation of neutrophils with lesser concentrations of cytotaxin results in inhibition of only a chemotactic response to the deactivating cytotaxin: the specific component. The basis of the nonspecific component of deactivation remains to be determined. Our failure to observe any loss of either the spontaneous or chemotactic migratory response of CGD neutrophils after exposure to larger doses of two cytotaxins together with the oxidative metabolic dysfunction of these cells suggest that autoxidative reactions may account for at least part of the loss of these migratory functions of normal cells on preincubation with cytotaxin. The particular by-products (1, 2, 11, 19) and the mechanism by which they might influence these migratory responses remain to be identified. Furthermore, it must be remembered that still other consequences of the interaction of PMN with cytotaxin such as loss of an esterase activity (31), release of lysosomal enzymes (4, 14) or increases in volume, agglutinability or adhesiveness (9, 24) may also contribute to some degree to the nonspecific component of deactivation.
